Risk Factors for Tamoxifen-Induced Ovarian Hyperstimulation in Breast Cancer Patients. Kim MK, Shin HC. Clin Breast Cancer 2020 Jan 28. pii: S1526-8209(20)30019.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim MK, Shin HC. Risk Factors for Tamoxifen-Induced Ovarian Hyperstimulation in Breast Cancer Patients. Clin Breast Cancer 2020 Jan 28. pii: S1526-8209(20)30019.
PMID: 32727665